BackSol-Gel Technologies Overview
Sol-Gel Technologies Ltd

Sol-Gel Technologies Debt to Equity

Valuation check: SLGL's debt-to-equity ratio is 0.02, below the Healthcare sector average of 0.3.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

0.02

Debt to Equity

0.02

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

Sol-Gel Technologies (SLGL) FAQ

As of the most recent data, SLGL shows a debt-to-equity ratio of 0.02. That is below the Healthcare sector average of 0.3. Scroll down for historical charts and peer comparison views.

The Healthcare sector average debt-to-equity ratio is about 0.3. Sol-Gel Technologies is at 0.02, which is lower that average. That is roughly 94.7% below the sector mean. Use the comparison chart on this page to see how SLGL stacks up against individual peers as well.

Investors watch SLGL's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Sol-Gel Technologies's latest reading is 0.02. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has Sol-Gel Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently 0.02) with ownership activity and broader fundamentals.

The Healthcare average debt-to-equity ratio is about 0.3, while SLGL is at 0.02. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.